FDA Drug recall D-0006-2017
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC…
- FDA Drug
- Class III
- terminated
- Published 2016-10-12
On 2016-10-12 the FDA classified a Class III recall of Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC… by Shire, citing presence of Foreign Tablets/Capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0006-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-09-02 |
| Published | 2016-10-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Shire |
| Distribution | US |
Product
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Reason
Presence of Foreign Tablets/Capsules
Identifiers
| ndc | 59417-101-10 |
|---|---|
| ndc | 59417-102-10 |
| ndc | 59417-103-10 |
| ndc | 59417-104-10 |
| ndc | 59417-105-10 |
| ndc | 59417-106-10 |
| ndc | 59417-107-10 |
| ndc | 59417-115-01 |
| ndc | 59417-116-01 |
| ndc | 59417-117-01 |
| ndc | 59417-118-01 |
| ndc | 59417-119-01 |
| ndc | 59417-120-01 |
| code_info | Lot # AF3360B; Exp. 04/19 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0006-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.